GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 7 analysts with an average price target of $65.91. This is a potential upside of $9.34 (16.51%) from yesterday's end of day stock price of $56.57.

Globus Medical's activity chart (see below) currently has 247 price targets and 163 ratings on display. The stock rating distribution of GMED is 10% SELL, 60% BUY and 30% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 94.89% with an average time for these price targets to be met of 307 days.

Highest price target for GMED is $103, Lowest price target is $70, average price target is $86.

Most recent stock forecast was given by WILLIAM PLOVANIC from CANACCORD on 22-Jul-2025. First documented stock forecast 16-Jun-2013.

Currently out of the existing stock ratings of GMED, 1 are a SELL (10%), 6 are a BUY (60%), 3 are a HOLD (30%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$90

$34.3 (61.58%)

$101

2 months 19 days ago
(22-Jul-2025)

3/5 (60%)

$36.99 (69.78%)

255

Hold

4 months 14 days ago
(27-May-2025)

1/1 (100%)

$4.73 (18.01%)

469

Buy

$70

$9.52 (15.74%)

$92

5 months 3 days ago
(08-May-2025)

7/8 (87.5%)

$14.18 (25.40%)

130

Hold

$80

$19.52 (32.28%)

$82

6 months 1 days ago
(10-Apr-2025)

20/23 (86.96%)

$7.41 (10.21%)

358

Buy

$103

$42.52 (70.30%)

$93

7 months 18 days ago
(23-Feb-2025)

18/19 (94.74%)

$22.98 (28.72%)

357

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 307 days on average for the stock forecasts to be realized with a an average price target met ratio 94.89

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

SANJIT SINGH

Which analyst has the most public recommendations on GMED (Globus Medical)?

Sanjit Singh works at MORGAN STANLEY and has 9 price targets and 20 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Matt Miksic with highest potential upside - $42.52

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$37.48

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?